Quest Diagnostics, Inc [DGX] stock is trading at $178.26, up 0.13%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DGX shares have gain 1.99% over the last week, with a monthly amount drifted -2.00%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on August 25, 2025, when Robert W. Baird downgraded its rating to a Neutral but kept the price target unchanged to $194 for it. Previously, Redburn Atlantic started tracking the stock with Buy rating on April 02, 2025, and set its price target to $195. On March 04, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $185 on the stock. Leerink Partners upgraded its rating to a Outperform and increased its price target to $174 on January 06, 2025. Morgan Stanley upgraded its rating to an Overweight and raised its price target to $172 on December 17, 2024. In a note dated October 23, 2024, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $157 to $182.
Quest Diagnostics, Inc [DGX] stock has fluctuated between $148.70 and $197.55 over the past year. Currently, Wall Street analysts expect the stock to reach $201.6 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $178.26 at the most recent close of the market. An investor can expect a potential return of 13.09% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Quest Diagnostics, Inc [NYSE:DGX] reported sales of 10.85B for the trailing twelve months, which represents a growth of 13.18%. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.14 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.88.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 176.95 points at the first support level, and at 175.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 179.48, and for the 2nd resistance point, it is at 180.70.
Ratios To Look Out For
For context, Quest Diagnostics, Inc’s Current Ratio is 1.13. Further, the Quick Ratio stands at 1.04, while the Cash Ratio is 0.2. Considering the valuation of this stock, the price to sales ratio is 1.83, the price to book ratio is 2.73 and price to earnings (TTM) ratio is 20.92.
Transactions by insiders
Recent insider trading involved PFEIFFER GARY M, Director, that happened on Oct 22 ’25 when 1482.0 shares were sold. Director, PFEIFFER GARY M completed a deal on Oct 22 ’25 to buy 1482.0 shares. Meanwhile, SVP & General Counsel PREVOZNIK MICHAEL E sold 227.0 shares on Sep 26 ’25.
